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Dendritic cells (DCs) have a pivotal role in the autoimmune
response of systemic lupus erythematosus. Plasmacytoid DCs
infiltrate the kidney of patients with lupus nephritis, but
factors regulating their recruitment to the kidney are
unknown. Chemerin is the recently identified natural ligand
of ChemR23, a receptor highly expressed by plasmacytoid
DCs. We performed immunohistochemical and
immunofluorescence analysis to study the ChemR23/
chemerin axis in renal biopsies from patients with lupus
nephritis. We found ChemR23-positive DCs had infiltrated the
kidney tubulointerstitium in patients with severe lupus
nephritis. Chemerin association with tubular epithelial cells
and renal lymphatic endothelial cells was found in patients
with lupus nephritis but not in normal kidneys. Proximal
tubular epithelial cells produced chemerin in vitro, which was
significantly down-modulated by added tumor necrosis
factor (TNF)-a and interferon-c as measured by quantitative
PCR and enzyme-linked immunosorbent assay. Interestingly,
TNF-a was capable of inducing a functionally active form of
renal chemerin, resulting in an efficient transendothelial
migration of plasmacytoid DCs measured in transwell
systems. Thus, the ChemR23/chemerin axis may have a role
in the recruitment of DCs within the kidney in patients
affected by lupus nephritis.
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Dendritic cells (DCs) are professional antigen-presenting
cells that patrol tissues to sense danger signals, activating
specific immune responses.1 Although all DCs are capable
of Ag uptake, processing, and presentation to naı¨ve T cells,
DC subtypes differ in location, migratory pathways, detailed
immunological functions, and differentiation pathways.2,3
One division is into myeloid DCs, which already have a
dendritic form and exhibit DC functions in steady state,
and precursors of DCs, which require further develop-
ment to acquire a dendritic form and full DC function.2
Plasmacytoid DCs, also known as natural interferon-produ-
cing cells, are one of the DC lineages appearing as DC
precursors.
A dysregulation in DC biology has been demonstrated
in patients affected by systemic lupus erythematosus
(SLE).4–6 In SLE patients, an enhanced production of type I
interferons by plasmacytoid DCs promotes the aberrant
presentation of auto-antigens to T and B cells by myeloid
DCs,7 which are actively involved in the phagocytosis of
apoptotic cells.5
SLE is characterized by multi-organ involvement6 and
nephritis, which occurs in up to 60% of patients.8 SLE
patients with nephritis have abundant infiltrate of plasma-
cytoid DCs mostly localized at tubulointerstitial level.9
However, the mechanism by which plasmacytoid DCs enter
the tubulointerstitium is not fully understood, although it is
likely that chemotactic factors are involved.
Recent data on SLE patients with skin involvement have
shown an increased number of plasmacytoid DCs expressing
the G-protein-coupled receptor ChemR23, at the level of skin
lesions. This receptor is able to drive plasmacytoid DC
migration in response to chemerin, a non-chemokine
chemoattractant polypeptide.10
Given the increased presence of plasmacytoid DCs at renal
level in SLE patients, aim of the present study has been to
investigate the possible role of the ChemR23/chemerin axis
in the recruitment of plasmacytoid DCs in kidney of patients
with lupus nephritis.
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RESULTS
ChemR23þ cells infiltrate kidney of SLE patients with
nephritis
Lupus nephritis is characterized by an increased recruitment
of plasmacytoid DCs, which express the ChemR23 receptor,
whose natural ligand is chemerin.10 We first investigated the
presence of cells expressing the ChemR23 receptor. We did
not detect infiltrating cell expressing the chemerin receptor
in normal renal tissue (Figure 1a). However, as shown in
Figure 1b, we found ChemR23þ cells in kidney from SLE
patients with nephritis, mostly localized at tubulointerstitial
level. At higher magnifications, ChemR23þ cells clearly
surrounded tubular epithelial cells, with a typical DC pattern
(Figure 1c). Moreover, ChemR23þ cells frequently localized
around the glomeruli (Figure 1d and e thin arrows). In
addition, we found ChemR23þ cells associated with renal
vessels (Figure 1f, arrow). No ChemR23þ cells were detected
in renal biopsies from patients with minimal change disease
(Figure 1g). Quantification of percentage of ChemR23þ
staining area (Figure 1h) revealed a significant increase of
ChemR23þ cells in class III–IV patients (4.4±1.1%)
compared with class I–II patients (1.1±2.1%).
ChemR23þ cell populations express specific markers of
human DCs
We then evaluated the phenotypical characteristics of
ChemR23þ infiltrating cells. In humans, markers for
plasmacytoid DCs include CD123 and BDCA-2.11,12 Dou-
ble-immunofluorescence staining on frozen sections from
kidneys of class IV lupus nephritis (Figure 2a–d) revealed that
CD123þ cells expressed also ChemR23. In addition, BDCA-
2þ plasmacytoid DCs colocalized with ChemR23 (Figure
2e-g). Finally, we found that rare ChemR23þ cells expressed
BDCA-1 (Figure 2h-j), a specific marker of myeloid DCs.
Expression of chemerin in renal biopsies
Considering the presence of infiltrating DCs expressing the
ChemR23 receptor, we then stained renal tissue with a
specific anti-chemerin antibody. Normal subjects, SLE
patients with lupus nephritis, and patients with minimal
change disease were therefore analyzed (Figure 3). We did
not find any sign of chemerin production in normal
kidney (Figure 3a). On the contrary, when we analyzed SLE
patients with nephritis, chemerin associated to renal
tubular epithelial cells was found (Figure 3b–e). The intensity
of chemerin staining varied between class II (Figure 3b)
and class IV (Figure 3c) lupus nephritis, indicating an
increased production in patients with worse kidney involve-
ment. In class V lupus nephritis, chemerin deposits were
significantly less present than in class III–IV specimens
(Figure 3d). No signal was observed in the minimal change
disease (Figure 3f).
Chemerin was also associated to lymphatic endothelium,
identified using an antibody recognizing podoplanin, a
specific marker for lymphatic endothelial cells. The lymphatic
endothelium in lupus nephritis expressed podoplanin along
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Figure 1 |ChemR23+ cells infiltrate kidney of systemic lupus
erythematosus patients with nephritis. Normal kidneys
(a), kidneys from patients affected by lupus nephritis (class IV; b–f),
from patients with minimal change disease (g) were used to
investigate the presence of plasmacytoid dendritic cells
expressing the ChemR23 receptor. No ChemR23þ cells were
observed in normal kidneys (a,  20) and in minimal change
disease (g,  20). Several ChemR23þ cells were present in the
tubulointerstitium of patients with class IV lupus nephritis
(b, d;  20). At a higher magnification (c,  100) ChemR23þ
cells showed a peritubular location (arrow). ChemR23þ cells
frequently localized around the glomeruli (d, e arrows).
ChemR23þ cells were detected in peritubular vessels (f, arrow;
 40). (h) Quantitative analysis of ChemR23 staining was obtained
indicating the percentage (%) of the total area that was positive
for the specific signal (Adobe Photoshop software).
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the vessel walls (Figure 3g), with a significant presence of
chemerin (Figure 3h). The yellow staining in Figure 3i indi-
cated that the two signals colocalized on lymphatic vessels.
Chemerin production by renal epithelial and endothelial cells
To test the hypothesis that renal tubular epithelial cells may
represent a significant source of chemerin, we performed
reverse transcription PCR (RT-PCR) experiments. We found
that proximal tubular epithelial cells expressed chemerin mRNA
in vitro (Figure 4a) and the use of a pro-inflammatory stimulus
such as tumor necrosis factor (TNF)-a was able to reduce
chemerin mRNA levels. On the contrary, an anti-inflammatory
stimulus such as dexamethasone plus 1,25 dihydroxyvitamin
D3, did not modify the chemerin mRNA expression (Figure 4a).
Next, we performed real-time RT-PCR analysis to quantify
chemerin mRNA expression in proximal tubular epithelial
cells cultured for 48h. As shown in Figure 4b, anti-inflammatory
stimulus such as transforming growth factor (TGF)-b did
not modify the basal level of chemerin mRNA expression
in proximal tubular epithelial cells. The same effect was seen
after exposure to dexamethasone and 1,25 dihydroxyvitamin
D3, that was reported to stimulate chemerin gene in stromal
cell line.13 When we used IL1-b we did not observe any
change in mRNA expression (Figure 4b). On the contrary,
interferon (IFN)-g and TNF-a were capable to downregulate
significantly chemerin mRNA expression in proximal tubular
epithelial cells (Figure 4b).
Considering the presence of ChemR23þ DCs around
renal vessels and the colocalization between chemerin and
endothelial cells, we also isolated renal CD146þ /CD105þ
endothelial cells from normal kidneys (Figure 4c) and
performed real-time RT-PCR analysis. As shown in Figure
4d, renal endothelial cells expressed the specific mRNA for
chemerin as the proximal tubular epithelial cells.
Regulation of chemerin production in tubular epithelial cells
As the major site of chemerin localization in SLE patient was
the renal tubules, we then studied the regulation of chemerin
production in proximal tubular epithelial cells in vitro.
Therefore, we stimulated cells with IFN-g and TNF-a for 72 h
and collected culture supernatants to perform sandwich
enzyme-linked immunosorbent assay (ELISA). Proximal
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Figure 2 |Characterization of ChemR23þ cells as plasmacytoid dendritic cells (DCs) and myeloid DCs in kidney of patients
with lupus nephritis. (a–d) Overlay double immunofluorescence of ChemR23 (green) and CD123 (red) together with TO-PRO-3
nuclear staining (blue) in renal biopsy of a patient with class IV lupus nephritis (b;  63). The enlargement (b), originating from the
area indicated by the white box in a, shows a double-labeling image illustrating the colocalization between the green (c) and red channels
(d). Merge image (e) of red (f; ChemR23) and green (g; BDCA-2) channels with TO-PRO-3-stained nuclei (blue). Merge image (h) of
red (i; ChemR23) and green (j; BDCA-1) channels with TO-PRO-3-stained nuclei (blue).
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tubular epithelial cells were capable to produce chemerin in
a concentration around 25 ng/ml in presence of culture
medium (Figure 5a). TNF-a and IFN-g significantly down-
regulated the release of chemerin after 72 h (Figure 5a).
Dose-response experiments on stimulated proximal tubular
epithelial cells showed that the production of chemerin
progressively increased in culture cells in normal medium
(Figure 5b). TNF-a used at the concentration of 5 and
10 ng/ml decreased chemerin production of 40–30%. A
stronger effect was induced by 50 ng/ml of TNF-a (70%
reduction of protein release). Under stimulation by IFN-g,
we found a decrease in chemerin production by 50±5.8%,
with no significant differences between the concentrations
used (200, 500, and 1000U/ml; Figure 5c).
TNF-a activates renal chemerin to attract plasmacytoid DCs
Finally, we tested whether chemerin produced by proximal
tubular epithelial cells was functionally active in the
recruitment of plasmacytoid DCs using a transendothelial
chemotaxis assay in presence of a specific blocking antibody
for ChemR23. This method, although indirect, provides a
precise indication about the presence of biological active
chemerin.14 Therefore, we isolated plasmacytoid DCs from
healthy subjects as previously described.10 Chemerin-induced
transendothelial migration of plasmacytoid DCs through
HUVEC monolayer was assessed using supernatants from
unstimulated and stimulated proximal tubular epithelial cells
as a source of chemoattractants. First, we tested the culture
media derived from unstimulated proximal tubular epithelial
cells that showed in vitro the major production of chemerin
(Figure 6a). Surprisingly, despite the high release of
chemerin by proximal tubular epithelial cells in basal
condition (25 ng/ml), we found a very low capacity to
induce plasmacytoid DC migration by those supernatants
(Figure 6a). The same effect was seen when we tested the
supernatants derived from IFN-g-activated proximal tubular
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Figure 3 | Expression of chemerin in renal biopsies. A mouse anti-human chemerin antibody was used in immunohistochemistry to
stain renal biopsies from normal (a;  20), lupus nephritis (b–e), and minimal change disease (f;  20). A specific but weak signal was
observed in tubular epithelial cells in class II lupus nephritis (b;  20). Chemerin was detected in tubular epithelial cells from class IV
lupus nephritis (c;  20). Class V lupus nephritis was characterized by a scarce staining for chemerin (d;  40). At higher magnification
( 100), chemerin was clearly detectable within tubular epithelial cells (e). Indirect immunofluorescence-double staining of kidney
section from class IV lupus nephritis with anti-podoplanin (g; red) and anti-chemerin (h; green) antibodies. Yellow colors indicated
colocalization of the red and green signal (i). TO-PRO-3 staining of DNA is shown in blue.
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epithelial cells that were characterized by low plasmacytoid
DCs migration (Figure 6a).
On the contrary, the supernatants derived from proximal
tubular epithelial cells stimulated by TNF-a were capable to
attract significantly the plasmacytoid DCs through the
endothelial cell monolayer (Figure 6a). This effect was
significantly inhibited by the use of anti-ChemR23 blocking
antibody (Figure 6b). This result showed that the recruitment
of plasmacytoid DCs by TNF-a-stimulated proximal tubular
epithelial cells supernatants was mediated by chemerin
interaction with the ChemR23 receptor and was likely due
to the ability of TNF-a to promote pro-chemerin conversion
into biologically active chemerin.
DISCUSSION
In this paper, we have demonstrated for the first time the
presence of chemerin at renal level in SLE patients affected by
nephritis. Chemerin has been detected in tubular epithelial
cells and lymphatic endothelial vessels of patients with severe
renal damage. In accordance, we have found infiltrating
ChemR23þ DCs localized at peritubular and periglomer-
ular levels, at the sites of chemerin production. In vitro,
chemerin was produced by endothelial and proximal tubular
epithelial cells. When they were stimulated by TNF-a and
IFN-g, proximal tubular epithelial cells significantly down-
regulated chemerin mRNA expression and protein release.
However, only TNF-a was likely capable to induce the
biological activation of chemerin, leading to active recruit-
ment of plasmacytoid DCs.
SLE is a multi-organ autoimmune syndrome, wherein
patients who develop lupus nephritis are regarded as those
with the worst prognosis and the highest morbidity rate.6
Patients with severe lupus nephritis have massive infiltrates of
plasmacytoid DCs at tubulointerstitial level, when compared
with patients with mild nephritis.9 In proliferative and non-
proliferative glomerulonephritis, plasmacytoid DCs have also
been found in significant numbers, along with myeloid DCs,
mainly localized at tubulointerstitial level.15 So far, the factors
regulating the recruitment of plasmacytoid DC at renal level
are unknown.
Recent data on SLE patients with skin involvement
showed an increased number of plasmacytoid DCs expressing
the G-protein-coupled receptor ChemR23 at the level of skin
lesions. This receptor has been shown to drive plasmacytoid
DC migration in response to chemerin, a non-chemokine
chemoattractant polypeptide, that has been found in spleen
and lymph nodes.10 Our data indicate that plamacytoid DCs,
and to a lower extent myeloid DCs, express the ChemR23
receptor, that might mediate their recruitment during renal
inflammation. In addition, we have shown that chemerin is
mainly produced by tubular epithelial cells that have a pivotal
role in the recruitment of leukocytes at renal level.16–20 The
local production of chemerin might be crucial to promote
the specific chemotaxis of DCs within the kidney at the
tubulointerstitial level. The association of chemerin to
lymphatic endothelial vessels suggests that this chemotactic
factor may also regulate the migration of DC toward draining
lymph nodes.21,22
The modulation of chemerin expression has been
investigated in other cellular systems. Corticosteroid, HGF,
and IL1-b have been shown to modulate chemerin
mRNA.23,24 Our analysis in proximal tubular epithelial cells
indicated that only TNF-a and IFN-g are able to modulate
chemerin production. A large body of evidence implicates
TNF-a in lupus nephritis, but with an ambiguous role.25
TNF-a is highly expressed at the renal level in this setting26
and can be detected in high concentration in SLE sera,
correlating with disease activity.27 Accordingly, IFN-g is also
overexpressed in lupus nephritis.25,28,29 As we have detected
chemerin in SLE patients with severe renal involvement, it
Ch
em
er
in
 [2
-Δ
Ct
]
0.09
Ba
sa
l
* **
TG
F-β IL-1
β
IFN
-γ
TN
F-α
DE
X +
 vit
 D3
0.07
0.05
0.03
0
Chemerin
Basal TNF-α DEX
β-Actin
a b
64
0
100 101 102
CD146
103 104
Ev
en
ts
64
0
100 101 102
CD105
103 104
M1
Ev
en
ts
c
0.015
0.010
0.005
0
Tubular 
cells
Endothelial
cells
Ch
em
rin
 [2
-
ΔC
t]
d
Figure 4 |Analysis of chemerin mRNA expression in renal
tubular epithelial and endothelial cells. (a) Reverse
transcription PCR (RT-PCR) analysis of mRNA isolated from
unstimulated proximal tubular epithelial cells (lane 1), and after
48 h of incubation with tumor necrosis factor (TNF)-a (lane 2) and
dexamethasone (lane 3). b-Actin was used as housekeeping gene.
(b) Real-time RT-PCR for chemerin in proximal tubular epithelial
cells stimulated for 48 h in presence of different factors. b-Actin
mRNA was used as internal control (*Po0.05 compared with basal
expression; **Po0.03 compared with basal expression). Bars
represent the mean values±s.d. of three independent
experiments. (c) Representative histograms of fluorescence-
activated cell sorting analysis on isolated renal endothelial cells,
showing the expression of CD146 and CD105 marker, confirming
their endothelial lineage. (d) Real-time RT-PCR analysis for
chemerin mRNA expression in renal endothelial cells and
proximal tubular epithelial cells under basal conditions. b-Actin
mRNA was used as internal control. Bars represent the mean
values±s.d. of three independent experiments. IFN, interferon;
IL, interleukin; TGF, transforming growth factor.
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might be possible to hypothesize the existence of some
chemerin-inducing factors that can counteract the inhibitory
effects of TNF-a and IFN-g, leading to a balance in protein
expression and production.
Chemerin is secreted as pro-chemerin, a poorly active
precursor protein that requires to be processed by proteases
into a functional form.30,31 It is important to realize that in
our study we could not discriminate the activation state
of chemerin on tissue, as the anti-chemerin monoclonal
antibody recognize an epitope located on both active
chemerin and pro-chemerin. Therefore, we cannot demon-
strate whether the chemerin detected in SLE patients with
nephritis was the inactive or active form of the protein.
We evaluated the levels of active chemerin, using a
chemotaxis assay in the presence of a specific blocking
antibody for ChemR23. This approach, although indirect,
provides a precise indication about the presence of biological
active chemerin.14 Our data in vitro clearly show that the
presence of TNF-a can induce the activation of chemerin
produced by renal epithelial cells, leading to specific
plasmacytoid DC recruitment across the endothelial mono-
layer. The generation of chemerin seems to be regulated first
at transcriptional level by TNF-a and IFN-g, both capable to
downregulate protein release. Next, a second level of
regulation occurs as the pro-chemerin requires activation
at extracellular level to acquire the biological activity. It has
been shown that proximal tubular epithelial cells treated with
TNF-a have an increase in plasminogen activating ability due
to the synthesis of the urokinase-type plasminogen,32 a serine
protease that is capable to activate chemerin.33 Therefore, it is
conceivable that TNF-a might be pivotal in the recruitment of
DCs by inducing the cleavage of pro-chemerin via the local
production of serine proteases in proximal tubular epithelial cells.
In conclusion, we demonstrated that the production of
chemerin occurs at renal level in SLE patients with nephritis.
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Figure 5 |Chemerin production by tubular epithelial cells
in vitro. (a) Effect of tumor necrosis factor (TNF)-a and interferon
(IFN)-g on the production of chemerin by proximal tubular
epithelial cells. After 72 h of stimulation, supernatants were
collected and assessed for chemerin levels by enzyme-linked
immunosorbent assay (ELISA). Results are expressed as
mean±s.d. of experiments in triplicate culture. (b) ELISA
experiments on chemerin secretion by proximal tubular epithelial
cells exposed to TNF-a at different concentrations. (c) ELISA
experiments on chemerin secretion by proximal tubular epithelial
cells exposed to IFN-g.
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Figure 6 |Renal chemerin induces transendothelial
migration of human plasmacytoid dendritic cells (DCs).
(a) Transendothelial migration experiments were used to test
the biological activity of chemerin produced by renal proximal
tubular epithelial cells. Black bars indicate the concentration
of chemerin in supernatants of proximal tubular epithelial cell
cultures (ng/ml). Gray bars indicate the percentage of
transmigrating plasmacytoid DCs across the endothelial
monolayer (% of plasmacytoid DCs input). Bars represent the
mean values±s.d. of three independent experiments (*Po0.05
by t-test). (b) Effect of anti-ChemR23 monoclonal antibody on
plasmacytoid DC transmigration. In vitro transmigration was
assessed in the absence (gray bars) or presence (white bars) of
anti-ChemR23 blocking antibody. Anti-ChemR23 antibody did not
block migration to CXCL12 indicating the specificity of the effect (not
shown). Bars represent the mean values±s.d. of three independent
experiments. IFN, interferon; TNF, tumor necrosis factor.
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The local production of chemerin is accompanied by
infiltrating ChemR23þ DCs localized at peritubular and
periglomerular level. In vitro, chemerin is produced by
proximal tubular epithelial cells and endothelial cells, with a
significant downregulation in protein synthesis and release
on TNF-a and IFN-g activation. Finally, the presence of
TNF-a is required to induce the active form of chemerin,
resulting in specific chemotactic effect on plasmacytoid DCs.
These findings strongly suggest a role for the ChemR23/
chemerin axis in the recruitment of DCs at renal level in
lupus nephritis.
MATERIALS AND METHODS
Immunofluorescence and immunohistochemistry
Renal tissue samples were obtained from 13 SLE patients with lupus
nephritis who underwent kidney biopsy in the period 2000–2009
(five classes I–II, five classes III–IV, three class V). Five normal
controls were obtained from apparently normal portion of kidneys
removed for renal cell carcinoma and a second control group of
renal tissue samples was also obtained from five minimal change
disease patients with proteinuria (more than 5 g per day) who
underwent renal biopsy. For all biopsy specimens, standard analysis
using immunofluorescence microscopy was performed. Acetone-
fixed frozen sections were rehydrated in phosphate-buffered saline,
blocked with fetal bovine serum containing 2% of bovine serum
albumin, and then were incubated with a mouse monoclonal
antibody against ChemR23 (1:15; IgG2b; clone 4C7)10 or rabbit
anti-ChemR23 polyclonal antibody (1:50; IgG; Abcam, Cambridge,
UK), mouse anti-chemerin monoclonal antibody (1:30; IgG1; clone
14G10), rabbit anti-CD123 polyclonal antibody (1:100; IgG; Santa
Cruz Biotechnology, Santa Cruz, CA), mouse anti-BDCA-2 mono-
clonal antibody (1:10; IgG1), mouse anti-BDCA-1 monoclonal
antibody (1:10; IgG2a; all Miltenyi Biotec, Bergisch Gladbach,
Germany), rabbit anti-podoplanin polyclonal antibody (1:100; IgG;
Novus Biologicals, Littleton, CO), a specific marker of lymphatic
endothelium. As secondary antibodies we used Alexa Fluor 488 goat
anti-mouse IgG and Alexa Fluor 555 goat anti-rabbit IgG
(Molecular Probes, Eugene, OR). The sections were counterstained
with TO-PRO-3 (Molecular Probes), coverslipped using Gel Mount
mounting medium (Biomeda, Foster City, CA), and sealed with
clear nail varnish. Negative controls were performed by using
irrelevant primary monoclonal antibodies as well as in double stains
secondary antibody specificity was confirmed using unmatched
primary and secondary antibodies. Specific fluorescence was
acquired by confocal laser scanning microscopy using the Leica
TCS SP2 (Leica, Wetzlar, Germany).
For the immunohistochemistry protocol, we used the same anti-
chemerin and anti-ChemR23 antibodies. The slides were first
deparaffinized in xylene, hydrated in graded ethanol, boiled in Tris-
EDTA buffer (pH 9) in the microwave for retrieving antigens and
blocked with Protein Block (Dako, Carpinteria, CA). The binding of
the secondary antibodies against mouse immunoglobulins was
visualized with the EnVision G|2 System/AP (Dako). Visualization
of alkaline phosphatase was performed by incubation in Permanent
Red Chromogen supplemented with Levamisole (Dako) for
blocking endogenous alkaline phosphatase, giving a red precipitate.
The sections were counterstained with hematoxylin and mounted in
Glycergel (Dako). Negative controls were obtained using irrelevant
antibodies.
Cell culture
Human renal proximal tubular epithelial cells obtained from Lonza
(Valais, Switzerland) were maintained in REGM medium (Lonza)
according to the manufacturer’s instructions. The cells were used at
passages 3 to 6 and grown on 6-well plates (Corning Life Sciences,
Acton, MA). To induce quiescence, we incubated proximal tubular
epithelial cells in fetal bovine serum-free media for 24 h. Then,
proximal tubular epithelial cells were stimulated with cytokines,
such as TNF-a, IFN-g, IL-1b, and TGF-b (Sigma-Aldrich, St Louis,
MO), and with an anti-inflammatory drug, dexamethasone sodium
phosphate (Hospira, Napoli, Italy). Proximal tubular epithelial cell
culture medium was changed every two days. The medium was
collected and analyzed at different time points.
Isolation and culture of renal endothelial cells
To isolate renal endothelial cells, we used the normal part of renal
cortex obtained from surgically removed kidneys. After dissection
and passage through a graded series of meshes,34 we used anti-
CD146 immunomagnetic microbeads (Miltenyi Biotec), according
to the manufacturer’s instructions. The phenotype of endothelial
cells was assessed by flow cytometric analysis using the following
antibodies: anti-human CD146 (Immunotech Beckman Coulter,
Marseille, France) and CD105 (R&D Systems, Minneapolis, MN)
PE-monoclonal antibody. Nonspecific sites were blocked with the
FcR blocking reagent. Data were collected and analyzed using
System II software (Beckman Coulter, Fullerton, CA). The isolated
renal endothelial cells were cultured in EGM medium (Lonza).
Semiquantitative and quantitative RT-PCR
Total RNA was extracted from the cells using QIA shredder and
RNeasy Mini Kit (QIAGEN, Valencia, CA) and 500 ng of RNA was
reverse transcribed with the High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA).
Chemerin gene and the endogenous control gene b-actin were
included in the same PCR reaction for semiquantitative RT-PCR. All
PCR reactions were verified to be in the linear range by testing with
different cycle numbers.
Quantitative real-time RT-PCR was performed on an iCycler
Thermal Cycler (Bio-Rad Laboratories, Hercules, CA) using the
Hs_RARRES2_1_SG QuantiTect Primer Assay (QIAGEN) in combina-
tion with SYBR Green dye. The relative amounts of chemerin mRNA
were normalized to b-actin mRNA as housekeeping gene.
ELISA
Chemerin levels in proximal tubular epithelial cell supernatant were
measured using the DuoSet ELISA Development kit (R&D Systems),
which does not discriminate between pro-chemerin and chemerin.
The antibody reagents were titrated and used as follows: mouse anti-
chemerin capture antibody used to coat plate at 4 mg/ml in
phosphate-buffered saline and biotinylated goat anti-chemerin
detection antibody used at 0.2mg/ml. Bound detection antibody
was detected using streptavidin-HRP and the absorbance was
measured at 450 nm with a correction wavelength of 550 nm using
a microplate reader DV 990 (Gio. De Vita & C., Rome, Italy).
Transendothelial migration assay
Human peripheral blood mononuclear cells were isolated from buffy
coats by Ficoll gradient (Amersham Biosciences, Buckinghamshire,
UK); peripheral blood plasmacytoid DCs were magnetically sorted
with blood DC Ag (BDCA)-4 cell isolation kits (Miltenyi Biotec), as
1234 Kidney International (2011) 79, 1228–1235
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previously described.30 Transendothelial migration assay was
evaluated using 24-well Costar Transwell chambers (5 mm pore size;
Corning Life Sciences). HUVEC (passage o5) were cultured to
confluent monolayers on transwell inserts pre-coated with gelatin.
Monolayers were rinsed with chemotaxis medium (RPMI 1640
containing 10% fetal calf serum) before use. Plasmacytoid DC
suspension (100 ml, 1–2 106 cells/ml) was seeded in the upper well
and 600 ml of proximal tubular epithelial cell supernatants, or
control medium, was added to the lower well. The chamber was
incubated at 37 1C in humidified atmosphere in the presence of 5%
CO2 for 4 h. Migrated cells were recovered from the lower well and
counted; results were expressed as the percentage of input cells. In
some experiments, plasmacytoid DCs were pre-incubated in the
presence of anti-ChemR23 (3mg/ml) antibody at 37 1C for 30min
before the chemotaxis assay.
Statistical analysis
Data were presented as mean±s.d. of triplicate analysis. Statistical
analysis was performed using paired, unpaired Student’s t-test or
analysis of variance, as appropriate. Differences were considered
statistically significant when P values were o0.05. Data were ana-
lyzed using GraphPad Prism (GraphPad software, San Diego, CA).
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